In vitro model of colonization resistance by the enteric microbiota: Effects of antimicrobial agents used in food-producing animals

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 4, 2008, Pages 1230-1237

  Wagner, R Doug ^a   Johnson, Shemedia J ^a   Cerniglia, Carl E ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCYCLITOL; AMINOGLYCOSIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; APRAMYCIN; BACITRACIN; CARBADOX; CEFALOTIN; CEPHALOSPORIN; CLINDAMYCIN; DIHYDROSTREPTOMYCIN; ERYTHROMYCIN; LINCOMYCIN; LINCOSAMIDE; MACROLIDE; NALIDIXIC ACID; NEOMYCIN; NOVOBIOCIN; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOXALINE DERIVATIVE; STREPTOGRAMIN; STREPTOMYCIN; SULFAMETHOXAZOLE; SULFONAMIDE; TETRACYCLINE; TYLOSIN; VANCOMYCIN; VIRGINIAMYCIN;

AGRICULTURE; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIOASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE CELL; INTESTINE FLORA; MICROBIAL COLONIZATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA SEQUENCE; SALMONELLA;

ANIMAL HUSBANDRY; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BIOLOGICAL ASSAY; CACO-2 CELLS; DRUG RESISTANCE, BACTERIAL; HUMANS; INTESTINES; SALMONELLA ENTERICA;

EID: 42049089724     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00852-07     Document Type: Article

References (41)

1. Aarestrup, F. M., and B. Carstensen. 1998. Effect of tylosin used as a growth promoter on the occurrence of macrolide-resistant enterococci and staphylococci in pigs. Microb. Drug Resist. 4:307-312.
2. Alander, M., I. De Smet, L. Nollet, W. Verstraete, A. von Wright, and T. Mattila-Sandholm. 1999. The effect of probiotic strains on the microbial flora of the simulator of the human intestinal microbial ecosystem (shime). Int. J. Food Microbiol. 46:71-79.
3. Bernet, M. F., D. Brassart, J. R. Neeser, and A. L. Servin. 1994. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell-attachment and cell-invasion by enterovirulent bacteria. Gut 38:852-857.
4. Bry, L., P. G. Falk, T. Midtvedt, and J. I. Gordon. 1996. A model of host-microbial interactions in an open mammalian ecosystem. Science 273:1380-1383.
5. Carman, R. J., and M. A. Woodburn. 2001. Effects of low levels of ciprofloxacin on a chemostat model of the human colonic microflora. Regul. Toxicol. Pharmacol. 33:276-284.
6. Carman, R. J., M. A. Simon, H. E. Petzgold III, R. F. Wimmer, M. R. Batra, A. H. Fernández, M. A. Miller, and M. Bartholomew. 2005. Antibiotics in the human food chain: establishing no effect levels of tetracycline, neomycin, and erythromycin using a chemostat model of the human colonic microflora. Regul. Toxicol. Pharmacol. 43:168-180.
7. Cerniglia, C. E. 2000. The JECFA and alternate approaches for determining ADIs for antimicrobial residues. Microb. Ecol. Health Dis. 1:30-34.
8. Cerniglia, C. E., and S. Kotarski. 2005. Approaches in the safety evaluations of veterinary antimicrobial agents in food to determine the effects on the human intestinal microflora. J. Vet. Pharmacol. Ther. 28:3-20.
9. Cerniglia, C. E., and S. Kotarski. 1999. Evaluation of veterinary drug residues in food for their potential to affect human intestinal microflora. Regul. Toxicol. Pharmacol. 29:238-261.
10. Coconnier, M.-H., V. Liévin, M. Lorrot, and A. L. Servin. 2000. Antagonistic activity of Lactobacillus acidophilus LB against intracellular Salmonella enterica-like Caco-2/TC-7 cells. Appl. Environ. Microbiol. 66:1152-1157.
11. Dewey, C. E., B. D. Cox, B. E. Straw, E. J. Bush, and H. S. Hurd. 1997. Associations between off-label feed additives and farm size, veterinary consultant use, and animal age. Prev. Vet. Med. 31:133-161.
12. CVMP-VICH Safety Working Group. 2004. Studies to evaluate the safety of residues of veterinary drugs in human food: general approach to establish a microbiological ADI. Topic GL36. Report CVMP/VICH/467/03-FINAL. CVMP-VICH Safety Working Group, London, United Kingdom.
13. Falk, P. G., L. V. Hooper, T. Midtvedt, and J. I. Gordon. 1998. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev. 62:1157-1170.
14. Ferraro, M. J., et al. 2001. Performance standard for antimicrobial susceptibility testing; eleventh international supplement. NCCLS (CLSI) document M100-S11, p. 112-113. NCCLS/CLSI, Wayne, PA.
15. Gillespie, J. R. 1997. Modern livestock and poultry production. Delmar Publishing, Albany, NY.
16. Greenless, K. J., A. Anadon, and C. E. Cerniglia. 2000. Lincomycin. Toxicological evaluation of certain veterinary drug residues in food. World Health Organization, Geneva, Switzerland.
17. Halling-Sorensen, B., N. S. Nors, P. F. Lanzky, F. Ingerslev, and L. Holten. 1998. Occurrence, fate, and effects of pharmaceutical substances in the environment - a review. Chemosphere 36:357-393.
18. Hirayama, K. 1999. Ex-germfree mice harboring intestinal microbial flora derived from other animal species as an experimental model for ecology and metabolism of intestinal bacteria. Exp. Anim. 48:219-227.
19. Holzapfel, W. H., P. Haberer, J. Snel, U. Schillinger, and J. H. Huis in't Veld. 1998. Overview of gut flora and probiotics. Int. J. Food Microbiol. 41:85-101.
20. Hudault, S., V. Lievin, M.-F. Bernet-Camard, and A. L. Servin. 1997. Antagonistic activity exerted in vivo by Lactobacillus easel (strain GG) against Salmonella typhimurium C5 infection. Appl. Environ. Microbiol. 63:513-518.
21. Joint FAO/WHO Expert Committee on Food Additives. 2002. Evaluation of certain veterinary drug residues in food: forty-eighth report of the joint FAO/WHO expert committee on food additives. WHO technical report series no. 911. World Health Organization, Geneva, Switzerland.
22. Macfarlane, G. T., and S. Macfarlane. 1997. Human colonic microbial flora: ecology, physiology and metabolic potential of intestinal bacteria. Scand. J. Gastroenterol. Suppl. 222:3-9.
23. Merck & Co., Inc. 1999. Apramycin, p. 119. in S. Budavari, M. J. O'Neil, A. Smith, and P. E. Heckelman (ed.), Merck index, 11th ed. Merck & Co., Inc., Rahway, NJ.
24. Muyzer, G., E. C. De Waal, and A. G. Uitterlinden. 1993. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl. Environ. Microbiol. 59:695-700.
25. Nisbet, D. J., G. I. Tellez, V. K. Lowry, and R. C. Anderson, et al. 1998. Effect of a commercial competitive exclusion culture (Preempt™) on mortality and horizontal transmission of Salmonella gallinarum in broiler chicks. Avian Dis. 42:651-656.
26. Pedroso, A. A., J. F. M. Menton, M. R. Lambais, A. M. C. Racanicci, F. A. Longo, and J. O. B. Sorbara. 2006. Intestinal bacterial community and growth performance of chickens fed diets containing antibiotics. Poult. Sci. 85:747-752.
27. Perrin-Guyomard, A., S. Cottin, D. E. Corpet, J. Boisseau, and J.-M. Poul. 2001. Evaluation of residual and therapeutic doses of tetracycline in the human-flora-associated (HFA) mice model. Regul. Toxicol. Pharmacol. 34: 125-136.
28. Perrin-Guyomard, A., J.-M. Poul, D. E. Corpet, P. Sanders, A. H. Fernández, and M. Bartholomew. 2005. Impact of residual and therapeutic doses of ciprofloxacin in the human-flora-associated mice model. Regul. Toxicol. Pharmacol. 42:151-160.
29. Perrin-Guyomard, A., J.-M. Poul, M. Laurentie, P. Sanders, A. H. Fernández, and M. Bartholomew. 2006. Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model. Regul. Toxicol. Pharmacol. 45:66-78.
30. Poxton, I. R., R. Brown, A. Sawyerr, and A. Ferguson. 1997. Mucosa-associated bacterial flora of the human colon. J. Med. Microbiol. 46:85-91.
31. Poxton, I. R., R. Brown, A. Sawyerr, and A. Ferguson. 1997. The mucosal anaerobic gram-negative bacteria of the human colon. Clin. Infect. Dis. 25(Suppl. 2):S111-S113.
32. Sandberg, P. 2000. Food safety: antimicrobial residues. Compend. Contin. Educ. Pract. Vet. 22:S118-S123.
33. Savage, D. C. 1977. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 31:107-133.
34. U.S. Food and Drug Administration. 1996. Guidance 52: microbiological testing of antimicrobial drug residues in food. U.S. Food and Drug Administration, Rockville, MD.
35. U.S. Office of Technology Assessment. 1995. Impacts of antibiotic drug resistant bacteria. U.S. Government Printing Office, Washington, DC.
36. Van den Bogaard, A. E., and E. E. Stobberingh. 2000. Epidemiology of resistance to antibiotics, links between animals and humans. Int. J. Antimicrob. Agents 14:327-335.
37. Wagner, R. D., and C. E. Cerniglia. 2002. An in vitro assay to evaluate competitive exclusion products for poultry. J. Food Prot. 65:746-751.
38. Wagner, R. D., E. S. Krul, and G. Schonfeld. 1992. Apolipoprotein expression and cellular differentiation in Caco-2 intestinal cells. Am. J. Physiol. 263(2 Pt 1):E374-E382.
39. Watts, J. L., et al. 1999. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard. NCCLS (CLSI) document M31-A. pp. 53. NCCLS/CLSI, Wayne, PA.
40. Witte, W. 2000. Ecological impact of antibiotic use in animals on different complex microflora: environment. Int. J. Antimicrob. Agents 14:321-325.
41. Yao, J. D. C. and R. C. Moellering, Jr. 2007. Antibacterial agents, p. 1077-1113. In P. R. Murray, E. J. Baron, J. H. Jorgenson, M. L. Landry, and M. A. Pfaller (ed.), Manual of clinical microbiology, vol. 1, 9th ed. ASM Press, Washington, DC.